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Abstract
Introduction: The detection of rosette-like clusters (RLC) of follicular cells in thyroid 
carcinoma has been reported mostly in the columnar cell variant of papillary thyroid 
carcinoma (PTC). Despite the fact that diagnosing variants of PTC is no longer en-
couraged by The Bethesda System for Reporting Thyroid Cytopathology, the identi-
fication of cytomorphological features such as RLC linked with these tumours might 
help reduce possible misinterpretation in thyroid fine needle aspiration (FNA) cytol-
ogy. We accordingly investigated the potential correlation of architectural patterns 
including RLC with PTC variants.
Methods: We analysed 225 thyroid FNA cytology cases diagnosed as suspicious for 
malignancy (SFM) and positive for malignancy (M) over a 1-year time where all sam-
ples had corresponding histology. We also included 150 benign lesions from the same 
period. The presence of RLC vs similar appearing solid clusters, papillary structures 
and microfollicles were evaluated. We also performed immunocytochemistry and 
molecular testing for BRAFV600E.
Results: We included 100 (44.4%) SFM favouring PTC and 125 (55.6%) M cases with 
cyto-histological correlation. On histology, all SFM and M cases showed malignancy 
including 140 (62.2%) classic PTC and 85 (37.8%) PTC variants. The cytomorphologi-
cal patterns in all FNA samples included solid (74%), papillary (89%), microfollicular 
(70%), and pseudo-RLC morphology (25.7%). We identified only pseudo-RLC in 33 
FNA specimens from PTC variant cases that included tall cell variant (42.4%), hobnail 
variant (21.2%) and miscellaneous variants (36.3%) of PTC. No definitive RLC were 
detected in our series. Immunocytochemistry and BRAFV600E were not specifically 
linked with an RLC pattern.
Conclusions: These findings demonstrate that in our dataset the architectural pattern 
of RLC was not recognised within PTC variants. However, we did identify a pseudo-
RLC pattern that was observed in association with tall cell variant and hobnail variant 
cases of PTC.
534  |     DELL'AQUILA Et AL.
1  | INTRODUC TION
Rosette and rosette-like patterns can be found in different tumours, 
particularly those from the nervous system.1 Histologically, a typical 
rosette is characterised by a small round group or cluster of cells 
organised in a spoke-wheel or halo arrangement around a central 
lumen. The name is derived from their morphological resemblance to 
rose windows found in gothic churches, such as those found in the 
Cathedral of Notre Dame in Paris.2-4 Whilst different authors have 
described rosette and rosette-like patterns as a manifestation of cer-
tain tumours, this architectural pattern alone is not pathognomonic 
of any specific tumour type.1-2 Their presence, in fact, may be asso-
ciated with various forms of tumour differentiation.1-10 True rosettes 
are a characteristic finding in neurological tumours.1 However, ro-
settes have also been identified in other neoplasms such as medullary 
thyroid carcinoma, osteosarcoma, fibromyxoid sarcoma, rhabdo-
myosarcoma, endometrial stromal sarcoma and some non-Hodgkin 
lymphomas.1-11 Pseudorosettes tend to be associated with neuro-
blastomas, medulloblastomas, malignant melanoma, Merkel cell 
carcinoma, other neuroendocrine tumours of the skin, primitive neu-
roendocrine tumour, retinoblastoma, ependymoma, neurocytoma, 
glioblastoma, Wilm tumour and pheochromocytoma.1-11
To the best of our knowledge, the histological identification of 
a rosette pattern in thyroid histological samples has not been well 
published. However, rosettes have been previously documented 
in cytological samples from benign and malignant lesions such as 
adenomatous goiter, insular carcinoma and medullary thyroid car-
cinoma).11-17 Sen et al also reported the presence of a rosette-like 
pattern in a fine needle aspiration cytology (FNAC) specimen of a 
well-differentiated thyroid follicular carcinoma diagnosed as colum-
nar cell variant (CCV) of papillary thyroid carcinoma (PTC).12 Only a 
few other papers have reported this finding associated with thyroid 
carcinoma in which a rosette-like pattern was linked with aggres-
sive variants of PTC including the tall cell variant (TCV) of PTC.13-17 
Therefore, whether a rosette-like pattern is indeed associated with 
CCV-PTC and its potential diagnostic value in thyroid cytology re-
mains unknown. To assess any possible correlation of rosette-like 
morphology with specific PTC variants, we accordingly examined a 
retrospective series of thyroid FNAC cases for such specific features.
2  | MATERIAL S AND METHODS
We received institutional (Catholic University of the Sacred 
Heart) ethical approval for this study. A retrospective search was 
performed for all thyroid FNACs diagnosed as SFM and M over a 
1-year period (January 2018 to December 2018) at the Catholic 
University “Agostino Gemelli” Hospital in Rome, Italy. Furthermore, 
to determine the presence of a rosette-like pattern in benign vs ma-
lignant thyroid entities, we included another 150 benign sequential 
lesions diagnosed during the same study period. The institutional 
electronic medical record system Armonia-Metafora, Italy (CU) was 
also searched for thyroidectomy specimens during the same study 
period. The patient's age, sex, FNAC diagnoses and follow-up infor-
mation were recorded. All available pathology slides were reviewed. 
The majority of the thyroid nodules were evaluated and biopsied 
under ultrasound guidance by clinicians and radiologists.
2.1 | Thyroid FNAC specimens
All aspirations (with usually two passes performed for each lesion) 
were performed with 25- 27G needles. No rapid on-site assessment 
for adequacy of material was done. All patients consented to their 
procedure. All FNAC specimens were processed using a ThinPrep 
5000TM processor (Hologic Co). Prepared slides were fixed in 95% 
methanol and stained with a Papanicolaou stain. Any remaining 
material was stored in Preservcyt solution for potential ancillary 
studies.
Specimen adequacy was determined according to the Bethesda 
and British RCPath classification schemes.18-19 The cytology cases 
were classified and diagnosed according to the new Italian Working 
Group SIAPEC-IAP classification.20-21 All of the cases were re-eval-
uated and then re-classified according to The Bethesda System 
for Reporting Thyroid Cytology II (TBSRTC, 2017).1936 For this 
retrospective study, analyses were conducted using TBSRTC ter-
minology. This case series included the following distribution of di-
agnoses: 5.9% non-diagnostic including cystic cases; 77.8% benign 
lesions (BL); 3% atypia of undetermined significance/follicular lesion 
of undetermined significance; 6.1% follicular neoplasms; 2.2% SFM 
and 5% malignant (M) cases. All cytology and histology cases were 
reviewed by two cytopathologists whilst the re-classification ac-
cording to TBSRTC was done by one cytopathologist (E.D.R.). Cases 
with an equivocal interpretation were subject to consensus review. 
The concordance between SIAPEC-IAP and TBSRTC classification 
systems was 95.9%.
According to the literature, rosettes are defined as a group of 
15 or fewer follicular cells with a circular arrangement and central 
lumen that may/may not be filled with colloid.18-19 Most of the cy-
toplasm of the cells in a rosette tends to be located towards the 
centre (i.e. nuclei are peripheral), implying that these cells are tall/
columnar in shape. At our institution, we utilise liquid-based cytol-
ogy (LBC) preparation vs the conventional slide method. Figure 1A,C 
and Table 1 compares the rosette-like clusters (RLC) as reported by 
Sen et al12 to microfollicular and papillary structures. By comparison, 
a microfollicle is also comprised of a group of 15 or fewer follicular 
K E Y W O R D S
microfollicular pattern, papillary pattern, PTC variant, rosette pattern, thyroid, thyroid 
malignancy
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cells with a circular arrangement and central area usually filled with 
colloid. However, these follicular cells are shorter (cuboidal) and thus 
exhibit less cytoplasm in the microfollicle centre. A micropapillary 
cluster is comprised of 15 or more follicular cells arranged around a 
central fibrovascular core. The individual follicular cells in a papillary 
cluster are also shorter (more cuboidal) and have minimal cytoplasm 
that typically does not merge toward the center of the cellular clus-
ter. Nonetheless, we only found a pseudorosette pattern in some 
cases. A pseudorosette pattern resembles rosettes, but does not 
exhibit the features depicted in Figure 1A and as described in the 
paper by Sen et al.12 The presence/absence of these different follic-
ular structures was recorded in our cohort of cases.
2.2 | Immunocytochemistry analysis
In our routine practice, we perform ancillary techniques including 
immunocytochemistry (ICC) and BRAFV600E analysis in all suspicious 
and malignant thyroid cytological cases. Specifically, we perform 
ICC on all LBC samples. HBME-1 and galectin-3 ICC is performed 
using a protocol previously described by our group.22-24 The mini-
mal percentage of adequate lesional cells for the performance of ICC 
evaluation was defined at 30% in LBC samples. Lesional cells were 
interpreted to be positive when at least 50% of the cells demon-
strated strong cytoplasmic staining. To avoid false negative and/or 
false positive yields, this 50% ICC cut-off value was also used for 
histological tissue sections. A case was considered to be overall posi-
tive for malignancy when there was concomitant expression of both 
immunomarkers. Adequate galectin-3 immunoreactivity was repre-
sented by cytoplasmic staining, and suitable HBME-1 staining was 
chiefly within the cytoplasm with accentuation on the cytoplasmic 
membrane and within the lumen. Positive controls included meso-
thelioma for HBME-1 (membranous positivity) and histiocytes for 
galectin-3 (cytoplasmic staining). Lymphocytes identified in the ma-
jority of the thyroid slides were used as a negative control.
2.2.1 | Molecular analysis for BRAF mutation
DNA was extracted from both LBC stored material and paraffin em-
bedded tissues, with 100% concordance. BRAF V600E mutational anal-
ysis was performed on DNA extracted from cytological and surgical 
specimens containing at least 70% tumour. Details of the protocol 
employed have been previously published by our group.25-28
2.3 | Histology specimens
All surgical specimens were fixed in 10% buffered formaldehyde, 
embedded in paraffin and 5-μm-thick sections then stained with 
haematoxylin-eosin. The diagnosis of classical variant of PTC was 
based on the presence of true papillary structures and distinctive 
nuclear features. The diagnosis of FVPTC relied upon the detection 
of follicular architecture coupled with the nuclear features of PTC 
in multiple foci. Encapsulated tumours with either lympho-vascular 
invasion (within the capsule or beyond) or capsular penetration were 
diagnosed as invasive FVPTC. All cases were classified according 
to the seventh edition of the tumour-node-metastasis-based stag-
ing system recommended by the American Joint Commission on 
Cancer.29 The different PTC variants were classified according to 
F I G U R E  1   Comparison of papillary, 
rosette and microfollicular structures. 
Drawing of the different patterns in: (A) 
classic rosette structure; (B) cluster of 
follicular neoplastic cells; (C) papillary 
structure. Papanicolaou stain, 200×, 
liquid-based cytology
TA B L E  1   Comparison of cytomorphological patterns
Follicular structure Rosette pattern Microfollicles Papillary clusters
Definition •  Cells with circular arrangement
•  15 or fewer cells
•  Cytoplasm merges toward centre
•  Most of the cytoplasm is located within 
centre (i.e. nuclei peripheral), implying 
the cells are tall/columnar
•  Central area can have a lumen (± filled 
with colloid)
•  Cells with circular arrangement
•  15 or fewer cells
•  Cytoplasm merges toward 
centre
•  Minimal cytoplasm/cell causes 
fewer to be located within 
centre
•  Cells shorter (cuboidal)
•  Central area usually has colloid
•  Cells with more elongated 
arrangement
•  15 or more cells
•  Cytoplasm need not merge 
toward centre
•  Minimal cytoplasm/cell
•  Cells shorter (cuboidal)
•  Central fibrovascular core
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the World Health Organisation 2017.30-31 For the definition of TCV 
of PTC, we adopted the standard definition of at least 30% of tall 
cell component. However, in our analysis we also included cases of 
PTC with a less than 30% TCV component. The histological diag-
nosis of non-invasive follicular thyroid neoplasm with papillary like 
nuclear features was rendered according to the criteria described by 
Nikiforov et al.24 However, in our institution neoplasm with papillary 
like nuclear features terminology was used for follicular neoplasms 
without any overt papillary structures.
2.4 | Statistical analysis
Statistical analysis was performed using GraphPad-Prism 5 software 
(Graph Pad Software, San Diego, CA, USA) and MedCalc version 
10.2.0.0 (MedCalc Software). Statistical comparison of continuous 
variables was performed using the Mann-Whitney U-test or paired 
t-test, as appropriate. Comparison of categorical variables was per-
formed using the χ2 statistic, and the Fisher's exact test. P-values 
<.05 were considered as statistically significant.
3  | RESULTS
Table 2 summarises the clinical-pathological features for our retro-
spective series. To validate the search for a rosette-like pattern in 
malignant lesions as reported by Sen et al,12 we selected SFM and 
M cases with a with cyto-histological correlation resulting in a histo-
logical diagnosis of PTC and its variants. Furthermore, to determine 
if there was a difference of a rosette-like pattern for benign and ma-
lignant thyroid entities, we also included 150 sequential benign le-
sions diagnosed during the same study period. The entire series was 
composed of 239 female and 136 male patients with an age range of 
9 to 82 years (mean: 36.5 years). The size of thyroid lesions subject 
to FNAC ranged from 5 mm to 65 mm in greatest dimension (median 
size = 14 mm). All sub-cm lesions were discovered during radiologi-
cal screening for causes unrelated to thyroid disease. There was no 
significant difference in the size of these thyroid nodules among the 
diagnostic entities. The cytological series included 150 BL (40%), 
100 SFM (26.6%) and 125 M (33.3%). Only 20 (13.3%) out of 150 
BL had histological follow-up, showing 15 goitre and five follicular 
adenoma cases. The histological diagnoses for SFM and positive for 
malignant cases included: 140 classical PTC (cPTC-62.2%) and 85 
PTC variants (37.8%).
The distribution of the PTC variants, analysed in Table 3, was 
characterised by 140 classic PTC, 19 pure TCV, 27 PTC with a less 
than 30% TCV component, 13 hobnail PTC variant, eight follicular 
variant of PTC (FVPTC), six Warthin-like PTC, five columnar cell vari-
ant of PTC (CCV-PTC), four cases with both TCV plus CCV-PTC, and 
three solid variant of PTC (Table 3). For the TCV cases, we included 
both pure TCV (19 cases) and also PTC cases with a TCV component 
(27 cases, 58.7%) that contained less than 30% tall cells. In Table 3 
we further evaluated the 85 PTC variants distributed according to 
their cytology diagnosis of SFM (33 cases) and positive for malig-
nancy (52 cases). On histology, the 33 SFM were diagnosed as six 
pure TCV and 14 PTC with a less than 30% TCV component, six hob-
nail PTC variant, one Warthin-like PTC, four FVPTC and two CCV-
PTC. The 52 malignant cases were diagnosed as 13 TCV and 13 PTC 
with less than 30% TCV, seven hobnail PTC variant, five Warthin-like 
PTC, four FVPTC, three CCV-PTC, four combined TCV and CCV, and 
three as solid variant of PTC (Table 3).
Tables 4 and 5 compare the distribution of the different follicular 
architectural patterns encountered in the different samples accord-
ing to FNAC and final histopathology diagnoses, respectively. In the 
150 benign cases we confirmed the presence of large sheets of fol-
licular cells, few follicular clusters, and lack of any papillary, rosette 
or pseudorosette patterns. Regardless of the FNAC diagnostic cate-
gory, Table 4 shows that solid (without either a rosette or a pseudoro-
sette pattern) clusters were present in all PTC cases. The different 
cytological architectural patterns (in order of decreasing frequency) 
showed that there were 225 cases with solid clusters of neoplas-
tic cells (100%), isolated follicular cells in 201 cases (89.3%), papil-
lary structures in 200 cases (88.8%), microfollicular clusters in 154 
cases (68.4%). None of our cases had an unequivocal RLC pattern. 
Nonetheless, we did identify a pseudorosette pattern in 33 cases 
(14.6%, Figure 2A-C and Figure 3A-B). Comparing these different cy-
tomorphological patterns stratified according to the FNAC diagnosis 
of SFM and positive for malignancy, we found that the number of 
cases with pseudorosettes was documented in 21 cases with M and 
12 in SFM without any significant statistical correlation (P > .001). 
The other cytomorphological patterns had a similar distribution in 
both SFM and malignant cases. In Table 5 we analysed these patterns 
TA B L E  2   Clinicopathological features of study cases
Parameter Quantity (n = 375)
Female 239 (63.7%)
Male 136 (36.2%)
Thyroid nodule size 6-65 mm
Cytological diagnosis BL = 150 (40%)
SFM = 100 (26.6%)
PM = 125 (33.3%)
Histological diagnosis (245 cases) 15 goitre (6.1%)
5 FA (2%)
cPTC = 140 (48.9%)







Abbreviations: BL, benign lesions; cPTC, classical PTC; FA, follicular 
adenoma; G, galectin-3; H, HBME-1; ICC, Immunocytochemistry; 
PM, positive for malignancy; PTC, papillary thyroid carcinoma; SFM, 
suspicious for malignancy.
*ICC and BRAFV600E only in SFM and M categories 
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specifically according to the different histological variants of PTC. A 
pseudorosette pattern was found in cases with a histological diagno-
sis of pure TCV (14 cases, 42.4%) and hobnail variant (seven cases, 
21.2%). Further, seven out of nine cases with a CCV component (in-
cluding three pure CCV-PTC and four mixed TCV and CCV-PTC) had a 
focal pseudorosette pattern. None of our cPTC cases showed an RLC 
component or a pseudorosette pattern. Of note, we did not find any 
pseudorosette cluster within the histological samples of our series.
None of our BL cases had been diagnosed with the support 
of ancillary techniques. ICC stain results are reported in Table 6. 
ICC results showed that the majority of our SFM and M cases (209 
cases, 92.8%) had a concordant positive immunopanel for HBME-1 
and galectin-3 with only 16 cases (7.1%) showing positivity for a sin-
gle immunomarker (i.e. HBME-1). For cases grouped in the SFM cat-
egory, ICC showed nine cases with negative staining for galectin-3 
and revealed 100% positivity for HBME-1. The cases interpreted as 
being positive for malignancy had positive ICC staining in all cases 
except for seven that only showed immunopositivity for HBME-1. 
None of our malignant lesions had a negative concordant panel.
The different cytomorphological patterns did not correlate with 
any of the analysed immunomarkers. BRAFV600E was expressed in 47 
cases out of 225 malignancies (21%). We found a 100% concordance 
between cytology and histology for BRAFV600E expression. The re-
sults of molecular testing for BRAFV600E demonstrated a lack of any 
statistical correlation between BRAFV600E and architectural patterns. 
In fact, we found that 88 cases (70.4%) were of BRAFV600E wild type 
phenotype whilst 37 M cases (29.6%) had a BRAF mutation (Table 6). 
Among the BRAFV600E mutated cases, we found 14 cPTC, SEVEN 
hobnail PTC and 16 TCV. Of note, we did not find any specific sig-
nificant statistical correlation between BRAF and the pseudorosette 
pattern (P > .001).
4  | DISCUSSION
It is well established that specific morphological patterns may 
be characteristic of particular tumours.1-2 Such patterns often 
play an important role in the pathological identification of these 







PTC TCV* TCV + CCV
Warthin-
like PTC
SFM 2 4 6 44 0 6 (14) 0 1
PM 3 4 7 96 3 13 (13) 4 5
Note: Including pure TCV and in brackets, cases of PTC with TCV component <30%.
Abbreviations: CCV-PTC, columnar cell variant of PTC; FVPTC, follicular variant of PTC; PM, positive for malignant; PTC, papillary thyroid carcinoma; 








SFM + PM 
(n = 225)
Solid clusters 150 (100%) 100 (100%) 125 (100%) 225 (100%)
Papillary 0 88 (88%) 112 (89.6%) 200 (88.8%)
Microfollicular 0 56 (56%) 98 (78.4%) 154 (68.4%)
Isolated follicular 
cells
0 94 (94%) 107 (85.6%) 201 (89.3%)
Pseudorosette-like 
clusters
O 12 (12%) 21 (16.8%) 33 (14.6%)
Abbreviations: BL benign lesions; PM, positive for malignancy; SFM, suspicious for malignancy.
TA B L E  4   Distribution of cases 
according to follicular architectural 
pattern based upon FNAC diagnoses


















Solid clusters 2 (40%) 8 (100%) 13 (100%) 3 (100%) 27 (58.6%) 4 (100%) 6 (100%) 140 (100%)
Papillary 2 (40%) 2 (25%) 8 (61.5%) 2 (66.6%) 29 (63%) 4 (100%) 6 (100%) 130 (92.8%)
Microfollicles 2 (40%) 3 (37.5%) 10 (76.9%) 2 (66.6%) 20 (43.4%) 4 (100%) 0 (%) 126 (90%)
Isolated cells 2 (40%) 8 (100%) 12 (92.3%) 3 (100%) 27 (58.6%) 4 (100%) 6 (100%) 140 (100%)
Pseudorosette-like clusters 3 (60%) 3 (25%) 7 (53.8%) 2 (33.3%) 14 (30.4%) 2 (50%) 2 (33.%) 0
Abbreviations: CCV-PTC, columnar cell variant of PTC; cPTC, classic PTC; FVPTC, follicular variant of PTC; H-PTC, Hobnail variant PTC; PTC, 
papillary thyroid carcinoma; S-PTC, Solid variant PTC; TCV, tall cell variant of PTC; W-PTC, Warthin-like PTC.
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specific entities. However, they are usually not pathognomonic of 
any one tumour. One such pattern observed in various tumours 
is the formation of rosettes or rosette-like structures. The term 
rosette has been attributed to a pattern resembling a flower, char-
acterised by cells radially organised around a centre. Four main 
kinds of rosette have been described with different morpho-
logical features including: (a) Homer Wright rosette; (b) Flexner-
Wintersteiner rosette; (c) ependymal rosette; and (d) perivascular 
pseudorosettes.1-10 Whilst these rosettes may not always be 
seen, their recognition is often helpful in the diagnosis of neu-
ral entities such as medulloblastoma/ primitive neuroendocrine 
tumour, retinoblastoma, ependymoma, central neurocytoma and 
pineocytoma.
To the best of our knowledge, the definition of a rosette pattern 
has not been reported in thyroid lesions based on histological sam-
ples. Nevertheless, whilst a few books and atlases have mentioned 
the possibility of focal rosette-like features, this has not been clearly 
linked with either a specific entity or PTC variant. Of note, a few pa-
pers have described the presence of a rosette-like component rep-
resenting a minor or focal feature in cytological samples from both 
benign and malignant thyroid lesions, even though they lacked pic-
tures demonstrating this pattern.11-17 In our series of 150 BL we did 
not find any true rosette or pseudorosette follicular structures, con-
firming that this pattern is likely linked more with malignant thyroid 
nodules. The case report by Sen et al is, to the best of our knowledge, 
the only paper reporting the presence of rosettes in a thyroid FNAC 
with CCV-PTC, which triggered the reason to undertake our study.12 
To the best of our knowledge, no prior large series has corroborated 
a correlation of a specific PTC variant with an RLC pattern. A few 
authors previously described microfollicles as rosettes in cases of in-
sular thyroid carcinoma and/or benign adenomatous lesions (14-18). 
However, their rosette-like pattern did not meet its strict definition.17
Since the first edition of TBSRTC, several new variants of thyroid 
carcinoma have been described.32-33 The revised second edition of 
TBSRTC even included a detailed definition with particular criteria 
F I G U R E  2   (A, B) Follicular cells in a pseudorosette-like pattern from a case of tall cell variant of papillary thyroid carcinoma (Papanicolaou 
stain, 200×, liquid-based cytology); (C) details of another pseudorosette-like patter from the same case (Papanicolaou stain, 400×, liquid-
based cytology)
F I G U R E  3   (A, B), Follicular cells in a 
pseudorosette-like pattern from a case 
of hobnail cell variant of papillary thyroid 
carcinoma (Papanicolaou stain, 400× 
liquid-based cytology); (B) details from 
the same case with a pseudorosette-like 
cluster in the left bottom and a neoplastic 
cluster in the upper right (Pap stain, 200× 
liquid-based cytology)
TA B L E  6   Correlation between diagnostic categories and 
ancillary techniques
Cytology diagnosis H+ G+ BRAFV600E
SFM (100 cases) 100 (100%) 91 (91%) 10 (10%)
PM (125 cases) 125 (100%) 118 (94.4%) 37 (29.6%)
Abbreviations: G, galectin-3; H, HBME-1; PM, Positive for malignancy; 
SFM, suspicious for malignancy.
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for some of these PTC variants.33 However, there was no mention 
of an RLC pattern in any of these PTC variants. Analysing published 
data from the literature, we found that very few authors mentioned 
the presence of rosettes and/or a pseudorosette architectural pat-
tern in association with thyroid carcinoma.31 Importantly, these pat-
terns were not linked with specific diagnostic or prognostic features. 
Honambirajan et al, however, did emphasise that rosettes may su-
perficially resemble the microfollicles of FVPTC and that their pres-
ence should thus raise suspicion for an aggressive PTC variant.13
According to TBSRTC, the recognition of PTC variants is gen-
erally unnecessary on FNAC given that precise subtyping is rarely 
possible or reliable due to difficulties in sampling the predominant 
pattern, due to the rarity of some PTC variants, and because of the 
morphological overlap with conventional PTC.32-33 Nevertheless, 
the recognition of certain PTC variants (e.g. TCV, CCV-PTC and 
hobnail variant) that manifest with an aggressive behavior may war-
rant recognising them on FNAC because they often require more 
aggressive therapy. In a recent review article, Rossi et al discussed 
the morphological features that may be associated with PTC vari-
ants.31 However, there were no details discussed regarding the rel-
evance of rosettes in PTC variants.31 By definition, variants of PTC 
must have some of the essential nuclear features of typical PTC in-
cluding nuclear groves, clearing and pseudoinclusions. In contrast 
to the relatively easy identification of TCV findings on FNAC, the 
recognition of CCV-PTC is more elusive since the typical features 
of PTC are not consistently found in this variant. TBSRTC defines 
CCV-PTC as a variant characterised by columnar cells with hyper-
chromatic, oval and pseudostratified nuclei with supranuclear or 
subnuclear cytoplasmic vacuoles resembling colonic epithelium or 
secretory-type endometrium. With regard to the architectural pat-
terns seen in CCV-PTC, TBSRTC mentions that neoplastic follicular 
cells may be arranged as papillae, clusters, flat sheets, and some-
times, small tubular structures but not RLC as observed by Sen and 
colleagues.12 As reported by several authors, our LBC series con-
firms some morphological differences with conventional slides. In 
particular, we confirmed a lack of unequivocal features of rosette 
clusters. However, we did appreciate that a few of the cases had a 
pseudorosette pattern.
Our series, involving a review of 1 year's worth of thyroid FNAC 
cases diagnosed as SFM or malignant, found that a few pseudoro-
sette clusters were present in 14 TCV and 7 hobnail variant cases 
of PTC. Apart from the case report by Sen et al,12 we did not un-
cover articles mentioning an association with rosettes and either 
the TCV or hobnail variant. Such pseudorosette pattern may be 
attributed to peculiar morphological features in these variants (tall 
cells and columnar features of neoplastic cells), and as such when 
detected could suggest a possible aggressive variant. Concerning 
CCV-PTC, we did not find a obvious RLC pattern but did document 
a few pseudorosette clusters in seven out of nine cases, including 
four cases where there was a combination of TCV and CCV-PTC. 
Furthermore, a few pseudorosette clusters were also recognised in 
a minority of the other PTC variants including one solid variant of 
PTC, two FVPTC and two Warthin-like variant cases. None of the 
conventional cPTC cases had either an RLC or pseudorosette pat-
tern identified, but did frequently contain papillary and microfol-
licular cell clusters. While ICC, especially HBME-1, demonstrated 
strong and diffuse positivity in all cases of PTC supporting this di-
agnosis, such staining did not show any correlation with RLC. For 
BRAFV600E, we found an association with the aggressive variants of 
PTC but no correlation with cytomorphological pattern. Compared 
to the literature, we found a low number of BRAFV600E mutated 
cases 47 (21% for SFM plus M) which might be attributed to the 
fact that cPTC and several of the PTC variants are frequently wild 
type BRAFV600E.
In conclusion, our analysis confirmed the presence of an RLC pat-
tern in several PTC variants, and that such rosettes were not associ-
ated with cPTC cases. Our data show that a pseudorosette pattern is 
possibly identified in the TCV, hobnail variant of PTC and CCV-PTC. 
Furthermore, none of our BL cases had a rosette or pseudorosette 
pattern, suggesting that their presence is most likely to be associated 
with malignant thyroid lesions. Another interesting point is the ab-
sence of pseudorosette clusters in histological samples, confirming 
that this architectural pattern is mostly seen in cytological samples. 
The detection of a pseudorosette architectural pattern combined 
with the typical cytological findings of classical nuclear and cellu-
lar features of conventional PTC might offer an additional feature 
in those cases of thyroid FNAC with an equivocal interpretation or 
scant neoplastic component.
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